The burden of hepatic diseases is substantial, demanding advanced therapeutic options. Stem cell therapies represent a remarkably hopeful avenue, offering the chance to restore damaged liver tissue and enhance clinical outcomes. Currently, research focuses on several approaches, including the delivery of induced pluripotent stem cells directly into